June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Correlation of Ultra-widefield Fluorescein Angiographic Features with Intraocular Cytokine Expression in Diabetic Macular Edema: Exploring the Angiographic-Biologic Phenotype
Author Affiliations & Notes
  • Christopher J. Mugnaini
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Joseph R Abraham
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Charles C. Wykoff
    Retina Consultants of Houston, Texas, United States
  • Leina Lunasco
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • David M Brown
    Retina Consultants of Houston, Texas, United States
  • sruthi arepalli
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Sunil K Srivastava
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Alison Martin
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Katie Gregory
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Jamie Reese
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Justis P Ehlers
    Cole Eye Institute , Cleveland Clinic , Jewett , Ohio, United States
  • Footnotes
    Commercial Relationships   Christopher Mugnaini, None; Joseph Abraham, None; Charles C. Wykoff, Adverum (F), Alimera Sciences (C), Allegran (F), Allegro (C), Allergan (C), Alynylam (C), Apellis (C), Apellis (F), Bayer (C), Clearside (F), Clearside (C), D.O.R.C. (C), EyePoint (F), EyePoint (C), Genentech/Roche (F), Genentech/Roche (C), Neurotech (F), Novartis (F), Novartis (C), Regeneron (F), Regeneron (S), Regeneron (C), Regenxbio (F), Samsung (F), Santen (F); Leina Lunasco, None; David Brown, Adverum (F), Allegran (F), Allergan (C), Apellis (F), Apellis (C), Bayer (C), Biotime (C), Chengdu Kanghong Biotechnology (C), Clearside (F), Gemini (C), Genentech/Roche (F), Heidelberg (C), Novartis (F), Novartis (C), OHR (C), Opthea (F), Optos (C), Regeneron (F), Regeneron (C), Regenxbio (F), Regenxbio (C), Samsung (F), Santen (F), Senju (C), Zeiss (C); sruthi arepalli, None; Sunil Srivastava, Allergan (F), Bausch and Lomb (C), Gilead (F), Leica (P), Regeneron (F), Santen (C); Alison Martin, None; Katie Gregory, None; Jamie Reese, None; Justis Ehlers, Aerpio (F), Alcon (F), Allergan (F), Allergro (C), Genentech/Roche (F), Leica (C), Leica (P), Novartis (F), Regeneron (F), Santen (C), Thrombogenics/Oxurion (F), Zeiss (C)
  • Footnotes
    Support  RPB Unrestricted Grant to the Cole Eye Institute RPB1508DM; NIH K23 -EY022947; Regeneron REGE1901JE
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4867. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christopher J. Mugnaini, Joseph R Abraham, Charles C. Wykoff, Leina Lunasco, David M Brown, sruthi arepalli, Sunil K Srivastava, Alison Martin, Katie Gregory, Jamie Reese, Justis P Ehlers; Correlation of Ultra-widefield Fluorescein Angiographic Features with Intraocular Cytokine Expression in Diabetic Macular Edema: Exploring the Angiographic-Biologic Phenotype. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4867.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The dominant underlying biologic pathways driving diabetic macular edema (DME) have been implicated as predictors of therapeutic response. Elucidating the relationship between these key cytokine expression profiles and imaging biomarkers could aid in precision medicine and therapeutic selection. This study investigates the association of intraocular cytokine expression and ultra-widefield fluorescein angiography (UWFA) quantitative imaging biomarkers in DME.

Methods : The DAVE study is a prospective clinical trial that included prospective collection of aqueous humor samples and UWFA at select timepoints. The IMAGINE analysis is a post-hoc assessment of image biomarker association with underlying intraocular cytokine expression. Cytokines were evaluated through multi-plex arrays that measured 54 cytokines associated with inflammation and angiogenesis. UWFA parameters were assessed quantitatively using an automated feature analysis platform with manual validation to determine ischemic and leakage indices and microaneurysm count. Cytokine concentrations and quantitative angiogram parameters were correlated using Pearson’s correlation coefficients.

Results : Twenty eyes were included with a mean age of 54 ± 10 years. Increased panretinal leakage index correlated with VEGF (r=0.55, p=0.012), IL-6 (r= 0.48, p=0.034), ANGPTL4 (r=0.64, p=0.0024), uPAR (r=0.49, p=0.028), MMP1 (r=0.48, p=0.03), while increased microaneurysms correlated with increased MCP-1 (r=.47, p=0.037), MCP-4 (r=0.57, p=0.008), and PECAM-1 (r=0.51, p=0.022). No statistically significant relationship was found between panretinal ischemic index and cytokine expression. However, zonal assessment of posterior pole ischemic index demonstrated correlation with IL12p40 (r=0.49, p=0.028) and TIMP-2 (r=0.49,p=0.03).

Conclusions : Quantitative UWFA imaging parameters correlated with multiple aqueous humor cytokine concentrations. In particular, panretinal leakage and microaneurysm count were associated with multiple unique cytokines. Further research is needed to assess the possible implications of utilizing these findings for evaluating treatment response.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×